Innovent Biologics, Inc.
IVBXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $834 | $298 | -$393 | -$889 |
| Dep. & Amort. | $266 | $0 | $199 | $183 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $342 | $259 | $298 | $347 |
| Change in WC | -$1,093 | $569 | -$119 | $828 |
| Other Non-Cash | -$36 | $377 | -$200 | $301 |
| Operating Cash Flow | $314 | $1,503 | -$216 | $771 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$103 | $0 | -$700 | -$521 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $647 | -$612 | $146 | -$1,202 |
| Investing Cash Flow | $545 | -$612 | -$554 | -$1,724 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $548 | $0 | -$330 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $100 | -$346 | $69 | $2,343 |
| Financing Cash Flow | $648 | -$346 | -$261 | $2,343 |
| Forex Effect | -$10 | $14 | -$2 | $24 |
| Net Chg. in Cash | $3,770 | -$1,714 | -$516 | $707 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $1,714 | $0 | $1,332 |
| End Cash | $3,770 | $0 | -$516 | $707 |
| Free Cash Flow | $211 | $1,237 | -$915 | $249 |